INVO Bioscience, Inc. Q1 2023 Earnings Call Transcript
| INVODelisted Stock | USD 0.72 0.02 2.70% |
About 61% of INVO Bioscience's investor base is looking to short. The analysis of current outlook of investing in INVO Bioscience suggests that many traders are alarmed regarding INVO Bioscience's prospects. INVO Bioscience's investing sentiment overview a quick insight into current market opportunities from investing in INVO Bioscience. Many technical investors use INVO Bioscience stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
INVO |
Operator Good day. And welcome to the INVO First Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode Operator Instructions.
Read at insidermonkey.com
 |
INVO Bioscience Fundamental Analysis
We analyze INVO Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of INVO Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of INVO Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
INVO Bioscience is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
INVO Bioscience Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with INVO Bioscience stock to make a market-neutral strategy. Peer analysis of INVO Bioscience could also be used in its relative valuation, which is a method of valuing INVO Bioscience by comparing valuation metrics with similar companies.
Peers
INVO Bioscience Related Equities
| ENTX | Entera Bio | 19.56 | ||||
| LIXT | Lixte Biotechnology | 4.95 | ||||
| ENVB | Enveric Biosciences | 2.56 | ||||
| NLSP | NLS Pharmaceutics | 0.92 | ||||
| CLPS | CLPS | 3.45 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in INVO Stock
If you are still planning to invest in INVO Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the INVO Bioscience's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |